Overview

To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.

Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This trial was designed to compare meal related inhalation of Technosphere/Insulin to subcutaneous regular insulin in patients with type 2 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Mannkind Corporation
Treatments:
Insulin
Insulin, Globin Zinc